Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
The study is going to be conducted to collect feedback from the users about operation of AMS collect parameter raw data from patients in hospital ward setting using the investigational system for use in current and future AMS engineering and regulatory purposes as deemed appropriate by the Sponsor.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Male or female aged 18 years or older (≥18 years);
- • 2. Able and willing to provide written informed consent independently.
- Exclusion Criteria:
- • 1. Have previously participated in this study (no subject may participate more than once);
- • 2. Have an implantable pacemaker;
- • 3. Diagnosed with infection requiring isolation; OR
- • 4. Known to be pregnant and/or breast feeding;
About Ge Healthcare
GE Healthcare is a leading global medical technology and digital solutions innovator, dedicated to improving patient outcomes through advanced imaging, monitoring, and diagnostics. With a commitment to enhancing healthcare delivery, GE Healthcare develops cutting-edge technologies and clinical applications that empower healthcare professionals to make informed decisions. By leveraging extensive research and development capabilities, the organization actively sponsors clinical trials aimed at validating new therapies and medical devices, ensuring that they meet the highest standards of safety and efficacy. Through collaboration with healthcare providers and institutions, GE Healthcare strives to drive innovation and improve the efficiency of healthcare systems worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Patients applied
Trial Officials
Meera Joshi, MBBS
Principal Investigator
St. Marys Hospital, London
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials